Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance) Meeting Abstract
| Authors: | Clarke, J. M.; Pang, H.; Starr, M. D.; Hatch, A. J.; Kindler, H. L.; O'Reilly, E. M.; Innocenti, F.; Venook, A. P.; Hurwitz, H.; Nixon, A. B. |
| Abstract Title: | Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance) |
| Meeting Title: | 2015 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2015 Jan 15-17 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-01-20 |
| Language: | English |
| ACCESSION: | WOS:000356883800304 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.3_suppl.306 |
| Notes: | Meeting Abstract: 306 -- Source: Wos |
